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Abstract
Plasmids encoding resistance and virulence properties in multidrug resistant (MDR) Salmonella enterica (S.) serovar
Typhimurium monophasic variant 4,[5],12:i:- isolates recovered from pigs and humans (2006-2008) in Europe were
characterised. The isolates were selected based on the detection by PCR-amplification of S. Typhimurium virulence plasmid
pSLT genes and were analysed by multi-locus sequence typing (MLST). The resistance genes present in the isolates and the
association of these genes with integrons, transposons and insertion sequences were characterised by PCR-sequencing, and
their plasmid location was determined by alkaline lysis and by S1-nuclease pulsed-field gel electrophoresis (PFGE) Southern-
blot hybridisation. Plasmids were further analysed by replicon typing, plasmid MLST and conjugation experiments. The 10 S.
4,[5],12,i:- selected isolates belonged to ST19. Each isolate carried a large plasmid in which MDR with pSLT-associated
virulence genes were located. After analysis, eight different plasmids of three incompatibility groups (IncA/C, IncR and IncF)
were detected. Two IncA/C plasmids represented novel variants within the plasmid family of the S. 4,[5],12:i:- Spanish clone,
and carried an empty class 1 integron with a conventional qacED1-sul1 39 conserved segment or an In-sul3 type III with estX-
psp-aadA2-cmlA1-aadA1-qacH variable region linked to tnpA440-sul3, part of Tn2, Tn21 and Tn1721 transposons, and ISCR2.
Four newly described IncR plasmids contained the resistance genes within In-sul3 type I (dfrA12-orfF-aadA2-cmlA1-aadA1-
qacH/tnpA440-sul3) and part of Tn10 [tet(B)]. Two pSLT-derivatives with FIIs-ST1+FIB-ST17 replicons carried cmlA1-[aadA1-
aadA2]-sul3-dfrA12 and blaTEM-1 genes linked to an In-sul3 type I integron and to Tn2, respectively. In conclusion, three
emerging European clones of S. 4,[5],12:i:- harboured MDR plasmids encoding additional virulence functions that could
contribute significantly to their evolutionary success.
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Introduction
The emergence of multiple clones of Salmonella enterica (S.)
serovar Typhimurium-like strains lacking expression of the second
flagellar antigen (S. 4,[5],12:i:- throughout the manuscript) has
been reported worldwide [1]. Since the mid-1990s in Europe, S.
4,[5],12:i:- isolates have been increasingly implicated in human
disease, and pig and pork products play an important role as a
source of infection [1,2]. Given the increase in their prevalence,
these isolates represent a public health hazard and have been
included in the European Salmonella control systems (http://eur-lex.
europa.eu Accessed 1 January 2014). In addition, the two major
clones circulating in Europe (labelled as Spanish and European
clones) show multidrug resistance (MDR) to four or more unrelated
classes of antimicrobials, making continued surveillance of their
emergence and spread particularly important. Isolates belonging to
the European clone exhibit resistance to ampicillin, streptomycin,
sulphonamides and tetracycline (tetraR-type AMP-STR-SUL-TET)
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due to the presence of a resistance region on the bacterial
chromosome, and lack the typical S. Typhimurium virulence
plasmid (94 kb, pSLT) [1–4]. In contrast, the isolates belonging to
the Spanish clone show a MDR phenotype with additional resistance
to chloramphenicol, gentamicin and trimethoprim (AMP-CHL-
GEN-STR/SPE-SUL-TET-TMP or variants therein) mediated by
large non-conjugative plasmids (IncA/C or IncA/C+IncN plasmids
of the pUO-STmRV1-like group) carrying the spv locus of the
Salmonella virulence plasmids [1,5,6]. In order to investigate the
presence and diversity of plasmids encoding resistance and virulence
properties, which could give a selective advantage to emerging clones
of S. 4,[5],12:i:- in Europe, isolates collected from different sources
and countries within the European Union Network of Excellence
(NoE) Med-Vet-Net were analysed.
Materials and Methods
Bacterial isolates and properties
The isolates included in this work belong to the S. 4,[5],12:i:-
European NoE Med-Vet-Net (www.medvetnet.org) WP21 collec-
tion. This collection [4], included 116 Salmonella monophasic
isolates recovered from human, pig and pork products (2006–
2008) provided by eight participating laboratories from six
countries (Public Health England, and the Animal Health and
Veterinary Laboratories Agency, UK; the Agence Franc¸aise de
Se´curite´ Sanitaire des Aliments, France, the Federal Institute for
Risk Assessment, Germany, the Istituto Superiore di Sanita`, Italy;
the National Institute of Public Health in Warsaw, Poland; the
Health Surveillance Centre (VISAVET), University Complutense
in Madrid, Spain and the Central Veterinary Institute of
Wageningen, the Netherlands). Data on features like phage type,
antimicrobial resistance pattern, XbaI-PFGE pattern and multi-
ple-locus variable-number tandem repeat analysis (MLVA) profile
of the isolates, were previously published [4]. Since the aim of the
present study was the detection and further characterization of
plasmids containing resistance and virulence genes, we followed
two criteria for selection within this collection: MDR phenotype
different than the tetraR-type of the European clone (character-
istically lacking the virulence pSLT plasmid) together with the
detection of the spvC gene (gene widely used as a molecular marker
for the detection of pSLT or pSLT-derivatives [7]). Only spvC-
positive isolates (10 isolates) were suspected to contain a hybrid
plasmid and were further analyzed. Multilocus sequence typing
(MLST) was performed in the present study according to the
website database recommendations (http://mlst.ucc.ie/mlst/dbs/
Senterica).
Antimicrobial susceptibility testing, detection of
resistance genes and characterisation of their genetic
environments
The isolates were tested by broth microdilution for their
antimicrobial susceptibility against a panel of 14 antimicrobials
(ampicillin, cefotaxime, ceftazidime, chloramphenicol, ciprofloxa-
cin, colistin, florfenicol, gentamicin, kanamycin, nalidixic acid,
streptomycin, sulfamethoxazole, tetracycline, and trimethoprim) as
previously described [8]. The results were analysed following the
cut-offs set by EUCAST (www.eucast.org). Genes responsible for
resistance to ampicillin [blaPSE-1, blaOXA-1-like, blaTEM-1-like],
chloramphenicol [catA1, cmlA1, floR], aminoglycosides [aac(3)-IV,
aadA1-like, aadA2, strA, strB], sulphonamides [sul1, sul2, sul3],
tetracycline [tet(A), tet(B)] and trimethoprim [dfrA1-like, dfrA12]
were studied by multiplex and simplex PCR-amplification [8].
The genetic environments were characterized by overlapping
PCR-amplification and sequencing (Table S2 and Figure S1).
Plasmid content and characterisation of ‘resistance-
virulence’ plasmids
The plasmids were classified by PCR-based replicon typing
including IncU and IncR replicons [9,10], and if appropriate, by
plasmid MLST (pMLST, http://pubmlst.org/plasmid/). The
conserved scaffold of IncA/C plasmids was screened by PCR as
reported previously [11]. pSLT-genes encoding virulence func-
tions other than spvC (rck, mig5 and srgB) were PCR tested. The
plasmid content of the S. 4,[5],12:i:- isolates (and transconjugants
if applicable) was determined by alkaline lysis and S1-nuclease-
PFGE. The profiles obtained were subsequently analysed by
Southern-blot hybridisation [6] using specific probes for spvC, 12
resistance genes [blaTEM-1-like, cmlA1, aac(3)-IV, aadA1-like, aadA2,
strA, sul1, sul2, sul3, tet(A), tet(B), dfrA12], five transposon/ISCR
markers [merA-Tn21, tnpR-Tn1721, tnpR-bla-Tn2, tetR-Tn10 and
rcr2-ISCR2], and four Inc replicons [A/C, R, FIIs and FIB].
Plasmids containing spvC plus resistance genes were labelled as
pMVN-STmRV (1 to 4) and pMVN-STmVR (1 to 2).
Mating experiments
The horizontal transmission capabilities of the plasmids were
investigated by conjugation experiments. For this analysis six
strains (two per VR- or RV- plasmid incompatibility group
detected) were chosen. These strains carried the following
plasmids: pMVN-STmRV1 and pMVN-STmRV2 of IncA/C
(160 kb); pMVN-STmRV3 (100 kb) and pMVN-STmRV6
(160 kb) of IncR and pMVN-STmVR1 (130 kb) and pMVN-
STmVR2 (160 kb) of IncF. Mating assays were performed in
liquid broth (30uC and 37uC) for 20 h, using S. 4,[5],12:i:- strains
as donors and rifampicin-resistant E. coli K-12 J53 as recipient.
Transconjugants were selected on Eosin-Methylene Blue agar
plates containing rifampicin (50 mg/L) plus either chloramphen-
icol (30 mg/L), sulphonamides (300 mg/L), tetracycline (30 mg/
L) and/or trimethoprim (10 mg/L).
Results and Discussion
In Salmonella enterica, resistance plasmids containing the spv
region appear to have evolved either by acquisition of virulence
genes by resistance plasmids of different incompatibility groups
(RV) or through the integration of resistance islands into serovar-
specific virulence plasmids (VR) [12]. In this study, both types
were detected among 10 S. 4,[5],12:i:- isolates recovered in the
United Kingdom, Spain and Italy. The isolates were epidemio-
logically unrelated [4] excepting two isolates from Italy which, as
determined in this work, could be considered as one strain (Table 1
and S1). All isolates were assigned by MLST to ST19, which
constitutes the main ST found in diphasic S. Typhimurium
(http://mlst.ucc.ie/mlst/dbs/Senterica) and in other monophasic
isolates with plasmid-encoded MDR [13]. In contrast, monophasic
isolates assigned to the European clone, characterised by the
chromosomally-encoded AMP-STR-SUL-TET phenotype, usual-
ly belong to ST34 and lack the serovar-specific virulence plasmid
[1–4]. Of note, MLST analysis suggests that the Spanish and other
plasmid-harbouring clones, such as those detected in this study,
originated independently from one or more S. Typhimurium
ancestor(s) distinct from that of the European clone.
In this study, both resistance-virulence and virulence-resistance
plasmids, with sizes ranging from ,100 to 160 kb, were identified
in S. 4,[5],12:i:- (Table 1). No isolate carried a 94 kb plasmid
consistent with pSLT. Each isolate was found to contain a RV or
VR plasmid belonging to incompatibility groups IncA/C, IncR or
IncF, with or without other co-resident plasmids.
Resistance-Virulence Plasmids in S. 4,[5],12:i:-
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IncA/C plasmids
Two 160 kb IncA/C plasmids, named pMVN-STmRV1 (found
in a human isolated from the UK) and pMVN-STmRV2 (from a
swine isolate from Spain), were found. According to their sizes,
resistance genes and mobile genetic elements carried, they
represent two new variants of the pUO-STmRV1-like group
typically found in the Spanish S. 4,[5],12:i:-clone [6] (Table 1,
Figure 1, Table S3). These two plasmids were the only ones to
carry the aac(3)-IV gene conferring gentamicin and tobramycin
resistance, a defective Tn1721 [tet(A)] transposon (Figure 1F),
Tn21-related sequences (tnpM, tnpR and merA, but negative for the
transposase gene), and ISCR2 linked to sul2. The sequence of the
A/C replicon amplicon (437 bp, accession numbers HF968758
and HF968759) of both plasmids was identical to the correspond-
ing fragment of the repA gene of pUO-STmRV1 (accession
number HF968757) [6]. This A/C subtype differs in 22 and five
nucleotides from the A/C1 and A/C2 replicons [14] affecting the
encoded RepA proteins, with one and two amino acid variations,
respectively [6]. Similar to pUO-STmRV1, pMVN-STmRV1 and
pMVN-STmRV2 lacked part of the IncA/C conserved backbone
including several genes of the tra region (PCR profiles according to
Welch et al. [11]: pUO-STmRV1 [1, 2, 3, 4, 2, 2, 2, 2, 2, 10,
11, 12], pMVN-STmRV1 [1, 2, 3, 4, 2, 2, 2, 2, 9, 10, 11, 12]
and pMVN-STmRV2 [1, 2, 3, 2, 2, 2, 2, 2, 9, 10, 11, 2]).
Consequently, they were not self-transferable, though pMVN-
STmRV2 generated a larger co-integrated plasmid after the
conjugation process (as demonstrated by hybridisation of the
plasmid DNA; data not shown), suggesting that it could be
mobilized by the co-resident IncFIB-ST20 R-plasmid (blaTEM-1) of
,100 kb. In agreement with the pUO-STmRV1 group, they were
also negative for the rck and srgB genes of pSLT. In summary, the
two new plasmid variants described here support the presence of S.
4,[5],12:i:- isolates of the Spanish clone in the United Kingdom.
Moreover, evidence of their occurrence in Portugal and France
has already been reported [15,16].
IncR plasmids
Six other isolates (five strains) collected in Italy (human) and
Spain (swine) contained four distinct plasmids with the IncR
replicon (pMVN-STmRV3-RV6). These plasmids shared a
common resistance pattern but differed in size (100 to 160 kb)
and pSLT-related genes (Table 1). All resistance genes harboured
by them, with the exception of tet(B), formed part of a sul3-type I
integron (intI1/dfrA12-orfF-aadA2-cmlA1-aadA1-qacH/tnpA440-sul3).
The tet(B) gene was found associated with Tn10-related sequences
(Figure 1B,G and Table S3). Like other reported IncR plasmids,
they appear to be non-conjugative and, together with resistance
functions, the acquisition of virulence genes from pSLT indicates
their ability to capture additional genetic information that could
bring an advantage to the host. As shown by the present study,
Figure 1. Schematic overview of the integrons (A to C) and transposons (D to G) detected in this study. The information of which
plasmid carried each structure is shown in Table 1. An overview of PCR mapping strategy designed to establish the structure and primers used are
shown in Figure S1 and Table S2, respectively. Please note that the scale is not the same for all schemes.
doi:10.1371/journal.pone.0089635.g001
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IncR plasmids represent a new genetic platform that will allow co-
selection of both virulence and resistance functions. Since the
definition of the IncR family in 2009 [10], resistance plasmids
belonging to this family and linked to quinolone and extended-
spectrum b-lactam resistance, have been increasingly reported in
enteric pathogens. However, to our knowledge this is the first
report describing IncR plasmids in S. 4,[5],12:i:- isolates, and in
fact, IncR was the most frequent replicon found in our collection.
IncF pSLT-derivatives
The two remaining isolates found in the United Kingdom
(swine), carried plasmids with both IncFIIs-ST1 and IncFIB-ST17
replicons. These plasmids (pMVN-STmVR1 and pMVN-
STmVR2), of 130 and 150 kb respectively, contained all pSLT
genes tested (spvC, rcK, mig5 and srgB) and could have been derived
from pSLT through acquisition of multiple resistance genes
(Table 1). In both, blaTEM-1 was linked to an apparently complete
copy of Tn2, while the remaining genes were associated with a
sul3-type I integron (intI1/dfrA12-orfF-aadA2-cmlA1-aadA1-qacH/
tnpA440-sul3) (Figure 1B,D and Table S3). Conjugation assays
demonstrated that only pMVN-STmVR2 was self-transferable
under the conditions used. Both plasmids co-reside in the same cell
with a 20 kb R-plasmid (carrying strA, sul2 and tet(A) genes). Based
on the resistance genes and associated genetic elements identified,
pMVN-STmVR1 and pMVN-STmVR2 seem to be related to
plasmids found in isolates of diphasic S. Typhimurium recovered
from pigs in the UK in a parallel study [17], thus suggesting a
genetic exchange between the two S. Typhimurium populations
co-existing in the same environment. Resistance derivatives of the
serovar-specific virulence plasmid of S. Typhimurium (pSLT) were
found in diphasic S. Typhimurium isolates recovered from clinical
and animal samples in different countries [12,17,18] but until now,
not in isolates belonging to the monophasic variant.
Conclusions
The public health risk associated with monophasic S. 4,[5],12:i:-
in Europe is demonstrated by an increased isolation rate from food
and human sources together with the MDR prevalence (http://
eur-lex.europa.eu, Accessed 1 January 2014). However, so far,
little is known about clones circulating in Europe which harbour
resistance plasmids carrying the spv locus of pSLT. Emerging
clones of S. 4,[5],12:i:- could have a selective advantage conferred
not only by MDR properties but also by virulence factors linked
together on the same plasmid. Accordingly, the role that these
genetic platforms could play on the emergence and/or spread of
this variant should be taken into consideration. In fact, within this
study we have described and characterised eight new variants
belonging to three Inc groups. Full sequencing methodologies will
help to clarify the molecular events responsible for the construc-
tion of these and other complex mosaic plasmids that contribute
significantly to the evolutionary success of certain pathogenic
bacterial clones. Because several S. Typhimurium monophasic
clonal lines have been increasingly associated with human
infections, the continuous surveillance of their properties, distri-
bution and spread is particularly important. In this context, the
molecular data reported here underline the need of coordinated
surveillance to provide additional information and shed light on
the knowledge of circulating clones of S. 4,[5],12:i:- in Europe.
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